These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 832379)

  • 1. Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities.
    Ratcliffe WA; Fletcher SM; Moffat AC; Ratcliffe JG; Harland WA; Levitt TE
    Clin Chem; 1977 Feb; 23(2 PT. 1):169-74. PubMed ID: 832379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD radioimmunoassay.
    Castro A; Grettie DP; Bartos F; Bartos D
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):879-86. PubMed ID: 4760895
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassay for lysergide (LSD) in illicit drugs and biological fluids.
    Loeffler LJ; Pierce JV
    J Pharm Sci; 1973 Nov; 62(11):1817-20. PubMed ID: 4758079
    [No Abstract]   [Full Text] [Related]  

  • 4. The development and evaluation of a 125I radioimmunoassay for the measurement of LSD in body fluids.
    Stead AH; Watton J; Goddard CP; Patel AC; Moffat AC
    Forensic Sci Int; 1986; 32(1):49-60. PubMed ID: 3770601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysergic acid diethylamide: radioimmunoassay.
    Taunton-Rigby A; Sher SE; Kelley PR
    Science; 1973 Jul; 181(4095):165-6. PubMed ID: 4736456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a commercial radioimmunoassay kit for the detection of lysergide (LSD) in serum, whole blood, urine and stomach contents.
    Altunkaya D; Smith RN
    Forensic Sci Int; 1990 Sep; 47(2):113-21. PubMed ID: 2227729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An online immunoassay for LSD: comparison with GC-MS and the Abuscreen RIA.
    McNally AJ; Goc-Szkutnicka K; Li Z; Pilcher I; Polakowski S; Salamone SJ
    J Anal Toxicol; 1996 Oct; 20(6):404-8. PubMed ID: 8889676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
    Cassells NP; Craston DH; Hand CW; Baldwin D
    J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with testing for lysergic acid diethylamide.
    Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
    Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of LSD intoxication by analysis of serum and urine.
    McCarron MM; Walberg CB; Baselt RC
    J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of LSD in human body fluids by high-performance liquid chromatography, fluorescence spectroscopy and radioimmunoassay.
    Twitchett PJ; Fletcher SM; Sullivan AT; Moffat AC
    J Chromatogr; 1978 Mar; 150(1):73-84. PubMed ID: 641124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body fluid levels of lysergide (LSD).
    Smith RN; Robinson K
    Forensic Sci Int; 1985 Aug; 28(3-4):229-37. PubMed ID: 4065782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New synthesis and characterization of (+)-lysergic acid diethylamide (LSD) derivatives and the development of a microparticle-based immunoassay for the detection of LSD and its metabolites.
    Li Z; Goc-Szkutnicka K; McNally AJ; Pilcher I; Polakowski S; Vitone S; Wu RS; Salamone SJ
    Bioconjug Chem; 1997; 8(6):896-905. PubMed ID: 9404664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassay analysis of lysergic acid diethylamide.
    Cody JT; Valtier S
    J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
    Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
    J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
    Vu-Duc T; Vernay A; Calanca A
    Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry.
    Canezin J; Cailleux A; Turcant A; Le Bouil A; Harry P; Allain P
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):15-27. PubMed ID: 11817305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
    Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.